ShadowBuys
Got $8K from the company’s PAC

Rep. John R. Curtis sold Abbott Laboratories (ABT)

Rep. John R. Curtis (R-UT) · $1K–$15K · traded Dec 4, 2023

Got money from this company’s PAC

Abbott Laboratories’s PAC gave $8K to Curtis’s campaign and leadership PAC in the 2023–24 and 2025–26 election cycles. See it on FEC.gov ↗

Company PACs are funded by employees, not the company itself, and give to many members of both parties. A donation doesn’t mean the trade was connected.

Transaction
Sold
Amount
$1K–$15K
Owner
Joint
Traded
Dec 4, 2023
Disclosed
Dec 15, 2023
Days to disclose
11
Asset type
Stock
As filed
Abbott Laboratories
Industry
Medical - Devices · Healthcare

Other trades in this filing

All of Curtis's trades →

Recent Congress trades in ABT

Company context for ABT

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. ABTContract award·USAspending

    ABT: Department of Health and Human Services contract award

    GIMC NUTRITION SERVICES - ABBOTT NUTRITION RETAIL - NUTRITIONAL SUPPLEMENT FOOD PRODUCTS AND SUPPLIES BPA

    First observed: Nov 8, 2026, 12:28 PM ESTEvent / period: Sep 19, 2023Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. ABTContract award·USAspending

    ABT: Department of Veterans Affairs contract award

    PH REF LAB INSTRUMENT MAINT

    First observed: Nov 8, 2026, 11:39 AM ESTEvent / period: Sep 9, 2022Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. ABTContract award·USAspending

    ABT: Department of Veterans Affairs contract award

    PROPRIETARY LABORATORY INSTRUMENT SUPPORT & MAINTENANCE

    First observed: Nov 8, 2026, 11:39 AM ESTEvent / period: Sep 16, 2022Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.